207 related articles for article (PubMed ID: 22970326)
21. CXCR4 is a novel target of cancer chemopreventative isothiocyanates in prostate cancer cells.
Sakao K; Vyas AR; Chinni SR; Amjad AI; Parikh R; Singh SV
Cancer Prev Res (Phila); 2015 May; 8(5):365-74. PubMed ID: 25712054
[TBL] [Abstract][Full Text] [Related]
22. Role of lipid peroxidation in cellular responses to D,L-sulforaphane, a promising cancer chemopreventive agent.
Sharma R; Sharma A; Chaudhary P; Pearce V; Vatsyayan R; Singh SV; Awasthi S; Awasthi YC
Biochemistry; 2010 Apr; 49(14):3191-202. PubMed ID: 20205397
[TBL] [Abstract][Full Text] [Related]
23. D,L-sulforaphane-induced apoptosis in human breast cancer cells is regulated by the adapter protein p66Shc.
Sakao K; Singh SV
J Cell Biochem; 2012 Feb; 113(2):599-610. PubMed ID: 21956685
[TBL] [Abstract][Full Text] [Related]
24. Sulforaphane Inhibits c-Myc-Mediated Prostate Cancer Stem-Like Traits.
Vyas AR; Moura MB; Hahm ER; Singh KB; Singh SV
J Cell Biochem; 2016 Nov; 117(11):2482-95. PubMed ID: 26990292
[TBL] [Abstract][Full Text] [Related]
25. Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells.
Bryant CS; Kumar S; Chamala S; Shah J; Pal J; Haider M; Seward S; Qazi AM; Morris R; Semaan A; Shammas MA; Steffes C; Potti RB; Prasad M; Weaver DW; Batchu RB
Mol Cancer; 2010 Mar; 9():47. PubMed ID: 20196847
[TBL] [Abstract][Full Text] [Related]
26. Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C.
Singh SV; Herman-Antosiewicz A; Singh AV; Lew KL; Srivastava SK; Kamath R; Brown KD; Zhang L; Baskaran R
J Biol Chem; 2004 Jun; 279(24):25813-22. PubMed ID: 15073169
[TBL] [Abstract][Full Text] [Related]
27. Chemoprevention of prostate cancer by d,l-sulforaphane is augmented by pharmacological inhibition of autophagy.
Vyas AR; Hahm ER; Arlotti JA; Watkins S; Stolz DB; Desai D; Amin S; Singh SV
Cancer Res; 2013 Oct; 73(19):5985-95. PubMed ID: 23921360
[TBL] [Abstract][Full Text] [Related]
28. Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells.
Pei Y; Wu B; Cao Q; Wu L; Yang G
Toxicol Appl Pharmacol; 2011 Dec; 257(3):420-8. PubMed ID: 22005276
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells.
Nair S; Barve A; Khor TO; Shen GX; Lin W; Chan JY; Cai L; Kong AN
Acta Pharmacol Sin; 2010 Sep; 31(9):1223-40. PubMed ID: 20729872
[TBL] [Abstract][Full Text] [Related]
30. Optimizing combination therapy in prostate cancer: mechanistic insights into the synergistic effects of Paclitaxel and Sulforaphane-induced apoptosis.
Habib TN; Altonsy MO; Ghanem SA; Salama MS; Hosny MA
BMC Mol Cell Biol; 2024 Mar; 25(1):5. PubMed ID: 38438917
[TBL] [Abstract][Full Text] [Related]
31. Diallyl trisulfide inhibits activation of signal transducer and activator of transcription 3 in prostate cancer cells in culture and in vivo.
Chandra-Kuntal K; Singh SV
Cancer Prev Res (Phila); 2010 Nov; 3(11):1473-83. PubMed ID: 20959517
[TBL] [Abstract][Full Text] [Related]
32. ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells.
Xu C; Shen G; Yuan X; Kim JH; Gopalkrishnan A; Keum YS; Nair S; Kong AN
Carcinogenesis; 2006 Mar; 27(3):437-45. PubMed ID: 16272172
[TBL] [Abstract][Full Text] [Related]
33. Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells.
Mohamed AA; Tan SH; Xavier CP; Katta S; Huang W; Ravindranath L; Jamal M; Li H; Srivastava M; Srivatsan ES; Sreenath TL; McLeod DG; Srinivasan A; Petrovics G; Dobi A; Srivastava S
Mol Cancer Res; 2017 Oct; 15(10):1308-1317. PubMed ID: 28607007
[TBL] [Abstract][Full Text] [Related]
34. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines.
Zayzafoon M; Abdulkadir SA; McDonald JM
J Biol Chem; 2004 Jan; 279(5):3662-70. PubMed ID: 14602722
[TBL] [Abstract][Full Text] [Related]
35. Sulforaphane, a cruciferous vegetable-derived isothiocyanate, inhibits protein synthesis in human prostate cancer cells.
Wiczk A; Hofman D; Konopa G; Herman-Antosiewicz A
Biochim Biophys Acta; 2012 Aug; 1823(8):1295-305. PubMed ID: 22640870
[TBL] [Abstract][Full Text] [Related]
36. Notch2 activation is protective against anticancer effects of zerumbone in human breast cancer cells.
Sehrawat A; Sakao K; Singh SV
Breast Cancer Res Treat; 2014 Aug; 146(3):543-55. PubMed ID: 25038880
[TBL] [Abstract][Full Text] [Related]
37. Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells.
Khurana N; Talwar S; Chandra PK; Sharma P; Abdel-Mageed AB; Mondal D; Sikka SC
Int J Oncol; 2016 Oct; 49(4):1609-19. PubMed ID: 27499349
[TBL] [Abstract][Full Text] [Related]
38. Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells.
Singh SV; Warin R; Xiao D; Powolny AA; Stan SD; Arlotti JA; Zeng Y; Hahm ER; Marynowski SW; Bommareddy A; Desai D; Amin S; Parise RA; Beumer JH; Chambers WH
Cancer Res; 2009 Mar; 69(5):2117-25. PubMed ID: 19223537
[TBL] [Abstract][Full Text] [Related]
39. Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer.
Khurana N; Kim H; Chandra PK; Talwar S; Sharma P; Abdel-Mageed AB; Sikka SC; Mondal D
Oncol Rep; 2017 Nov; 38(5):2774-2786. PubMed ID: 28901514
[TBL] [Abstract][Full Text] [Related]
40. The Role of Lysosome-associated Membrane Protein 2 in Prostate Cancer Chemopreventive Mechanisms of Sulforaphane.
Hahm ER; Singh KB; Kim SH; Powolny AA; Singh SV
Cancer Prev Res (Phila); 2020 Aug; 13(8):661-672. PubMed ID: 32434809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
